Afluria® Quadrivalent 2023 – 2024 Flu Vaccine 60 mcg / 0.5 mL – (3 Years+) Prefilled Syringe 0.5 mL

Call or Live Chat now for current pricing and availability.
RX License Required.

Flu Season is here! Stock up on all your Afluria Flu Vaccine season needs today.

• AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
• AFLURIA QUADRIVALENT is approved for use in persons 3 Years of age and older
• AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2023 – 2024 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2023 – 2024 Northern Hemisphere influenza season:
• A/Brisbane/02/2018 (IVR-190) (an A/Brisbane/02/2018 (H1N1)pdm09 – like virus), A/Kansas/14/2017 (X-327) (an A/Kansas/14/2017 (H3N2) – like virus), B/Maryland/15/2016 (a B/Colorado/06/2017 – like virus) and B/Phuket/3073/2013 BVR-1B (a B/Phuket/3073/2013 – like virus). A 0.25 mL dose contains 7.5 mcg HA of each of the same four influenza strains.

This Is A Cold Product!!!

Manufacturer # 33332032303
NDC # 33332-0323-03
Product Insert Sheet
Similar Products